Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:35:26.165Z.
Calculation as of: 2026-10-06T13:35:26.165Z.
Quote observation: 2026-10-06T13:33:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ca6b3f945453907090b614e1109f6f6fce8b12406cb587c45253d0481e46e17d
EARNINGS YIELD
N/A
Market Cap
$32.55M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $34.65M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.85M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.42M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.55M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.68M | 116.48% | 90.36% | 90.36% | 90.36% |
| BeyondSpring Inc. (BYSI)vs › | $32.12M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $37.13M | N/A | 0.42% | 0.42% | 1.38% |
| Context Therapeutics Inc. (CNTX)vs › | $31.39M | N/A | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $29.91M | N/A | 0.12% | 0.12% | 0.12% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
